TAAR6 variations possibly associated with antidepressant response and suicidal behavior

Psychiatry Research

Volumn 180, Issue 1, 2010, Pages 20-24

  Pae, Chi Un ^a,b   Drago, Antonio ^c   Kim, Jung Jin ^a   Patkar, Ashwin A ^b   Jun, Tae Youn ^a   De Ronchi, Diana ^c   Serretti, Alessandro ^c  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antidepressant response; Association study; Gene; Suicide; Trace amine receptor 6

Indexed keywords

ALPRAZOLAM; AMINO ACID RECEPTOR; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLONAZEPAM; CYTOSINE; DIAZEPAM; DOSULEPIN; FLUOXETINE; GUANINE; LORAZEPAM; MIRTAZAPINE; PAROXETINE; PROTEIN TAAR6; THYMINE; TRAZODONE; UNCLASSIFIED DRUG; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAMILTON SCALE; HETEROZYGOTE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; CELL CYCLE PROTEINS; DEPRESSIVE DISORDER; FEMALE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SUICIDE;

EID: 77958164862     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.08.007     Document Type: Article

References (35)

1. Abou Jamra R., Sircar I., Becker T., Freudenberg-Hua Y., Ohlraun S., Freudenberg J., Brockschmidt F., Schulze T.G., Gross M., Spira F., Deschner M., Schmal C., Maier W., Propping P., Rietschel M., Cichon S., Nothen M.M., Schumacher J. A family-based and case-control association study of trace amine receptor genes on chromosome 6q23 in bipolar affective disorder. Molecular Psychiatry 2005, 10:618-620.
2. Amann D., Avidan N., Kanyas K., Kohn Y., Hamdan A., Ben-Asher E., Macciardi F., Beckmann J.S., Lancet D., Lerer B. The trace amine receptor 4 gene is not associated with schizophrenia in a sample linked to chromosome 6q23. Molecular Psychiatry 2006, 11:119-121.
3. Berry M.D. Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. Journal of Neurochemistry 2004, 90:257-271.
4. Blows W.T. Neurotransmitters of the brain: serotonin, noradrenaline (norepinephrine), and dopamine. Journal of Neuroscience Nursing 2000, 32:234-238.
5. Branchek T.A., Blackburn T.P. Trace amine receptors as targets for novel therapeutics: legend, myth and fact. Current Opinion in Pharmacology 2003, 3:90-97.
6. Bunzow J.R., Sonders M.S., Arttamangkul S., Harrison L.M., Zhang G., Quigley D.I., Darland T., Suchland K.L., Pasumamula S., Kennedy J.L., Olson S.B., Magenis R.E., Amara S.G., Grandy D.K. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Molecular Pharmacology 2001, 60:1181-1188.
7. Cavalli Sforza L. The History and Geography of Human Genes 1994, Princeton University Press, Princeton, New Jersey, USA.
8. Duan J., Martinez M., Sanders A.R., Hou C., Saitou N., Kitano T., Mowry B.J., Crowe R.R., Silverman J.M., Levinson D.F., Gejman P.V. Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. American Journal of Human Genetics 2004, 75:624-638.
9. Duan S., Du J., Xu Y., Xing Q., Wang H., Wu S., Chen Q., Li X., Shen J., Feng G., He L. Failure to find association between TRAR4 and schizophrenia in the Chinese Han population. Journal of Neural Transmission 2006, 113:381-385.
10. Esposito E. Serotonin-dopamine interaction as a focus of novel antidepressant drugs. Curr. Drug Targets 2006, 7:177-185.
11. Fanous A.H., Neale M.C., Webb B.T., Straub R.E., Amdur R.L., O'Neill F.A., Walsh D., Riley B.P., Kendler K.S. A genome-wide scan for modifier loci in schizophrenia. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 2007, 144:589-595.
12. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-Clinician Version (SCID-CV) 1997, American Psychiatric Press, Washington (DC).
13. Fisher R.A. On the interpretation of ?2 from contingency tables, and the calculation of P. Journal of the Royal Statistical Society 1922, 85:87-94.
14. Geracitano R., Federici M., Prisco S., Bernardi G., Mercuri N.B. Inhibitory effects of trace amines on rat midbrain dopaminergic neurons. Neuropharmacology 2004, 46:807-814.
15. Guy, W., 1976, ECDEU Assessment manual for psychopharmacology: revised (76-338, D. P. N. A., ed.), Rockville, MD, pp. 534-537.
16. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960, 23:56-62.
17. Ikeda M., Iwata N., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshita Y., Inada T., Ozaki N. No association of haplotype-tagging SNPs in TRAR4 with schizophrenia in Japanese patients. Schizophrenia Research 2005, 78:127-130.
18. Lewin A.H. Receptors of mammalian trace amines. American Association of Pharmaceutical Scientists Journal 2006, 8:E138-E145.
19. Lindemann L., Hoener M.C. A renaissance in trace amines inspired by a novel GPCR family. Trends in Pharmacological Sciences 2005, 26:274-281.
20. Lindemann L., Ebeling M., Kratochwil N.A., Bunzow J.R., Grandy D.K., Hoener M.C. Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 2005, 85:372-385.
21. Liu C., Shi J., Badner J.A., Zou H., Qian Y., Gershon E.S. No association of trace amine receptor genes with bipolar disorder. Molecular Psychiatry 2007, 12:979-981.
22. Montgomery S., Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979, 134:382-389.
23. Murphy D.L., Karoum F., Pickar D., Cohen R.M., Lipper S., Mellow A.M., Tariot P.N., Sunderland T. Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline). Journal of Neural Transmission Suppl 1998, 52:39-48.
24. Owens M.J. Selectivity of antidepressants: from the monoamine hypothesis of depression to the SSRI revolution and beyond. Journal of Clinical Psychiatry 2004, 65(Suppl 4):5-10.
25. Pae C.U., Yu H.S., Amann D., Kim J.J., Lee C.U., Lee S.J., Jun T.Y., Lee C., Paik I.H., Patkar A.A., Lerer B. Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample. Journal of Psychiatric Research 2008, 42:35-40.
26. Posner K., Oquendo M.A., Gould M., Stanley B., Davies M. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. American Journal of Psychiatry 2007, 164:1035-1043.
27. Ricci L.C., Wellman M.M. Monoamines: biochemical markers of suicide?. Journal of Clinical Psychology 1990, 46:106-116.
28. Roy A. Genetic and biologic risk factors for suicide in depressive disorders. Psychiatric Quarterly 1993, 64:345-358.
29. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., Burrell G.J., Rice J.P., Nertney D.A., Olincy A., Rozic P., Vinogradov S., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Crowe R.R., Cloninger C.R., Martinez M., Gejman P.V. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. American Journal of Psychiatry 2008, 165:497-506.
30. Sullivan P.F. Spurious genetic associations. Biological Psychiatry 2007, 61:1121-1126.
31. Venken T., Alaerts M., Adolfsson R., Broeckhoven C.V., Del-Favero J. No association of the trace amine-associated receptor 6 with bipolar disorder in a northern Swedish population. Psychiatric Genetics 2006, 16:1-2.
32. Vladimirov V., Thiselton D.L., Kuo P.H., McClay J., Fanous A., Wormley B., Vittum J., Ribble R., Moher B., van den Oord E., O'Neill F.A., Walsh D., Kendler K.S., Riley B.P. A region of 35kb containing the trace amine associate receptor 6 (TAAR6) gene is associated with schizophrenia in the Irish study of high-density schizophrenia families. Molecular Psychiatry 2007, 12:842-853.
33. White B. A heteroskedasticity-consistent covariance matrix estimator and a direct test for hetereoskedasticity. Econometrica 1970.
34. Wolinsky T.D., Swanson C.J., Smith K.E., Zhong H., Borowsky B., Seeman P., Branchek T., Gerald C.P. The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav. 2007, 6:628-639.
35. Zucchi R., Chiellini G., Scanlan T.S., Grandy D.K. Trace amine-associated receptors and their ligands. British Journal of Pharmacology 2006, 149:967-978.